Pediatrix Medical Group, Inc.
MD
$19.70
-$0.19-0.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.92% | -4.21% | -3.08% | -1.13% | 0.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.92% | -4.21% | -3.08% | -1.13% | 0.92% |
| Cost of Revenue | -8.88% | -9.74% | -7.40% | -4.19% | -0.92% |
| Gross Profit | 8.66% | 16.22% | 13.35% | 10.45% | 7.78% |
| SG&A Expenses | 0.99% | 4.70% | 3.85% | 3.57% | 4.79% |
| Depreciation & Amortization | -32.27% | -32.97% | -36.39% | -27.38% | -10.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.01% | -8.38% | -6.61% | -3.70% | -0.41% |
| Operating Income | 25.81% | 42.45% | 39.69% | 30.12% | 16.36% |
| Income Before Tax | 313.57% | 174.64% | 152.86% | -32.37% | -109.56% |
| Income Tax Expenses | 2,346.65% | 313.28% | 297.71% | -86.16% | -118.86% |
| Earnings from Continuing Operations | 266.94% | 163.89% | 143.64% | -16.70% | -64.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 266.94% | 163.89% | 143.64% | -16.70% | -64.00% |
| EBIT | 25.81% | 42.45% | 39.69% | 30.12% | 16.36% |
| EBITDA | 17.14% | 29.41% | 24.71% | 18.74% | 11.28% |
| EPS Basic | 263.20% | 162.56% | 142.82% | -17.42% | -64.61% |
| Normalized Basic EPS | 43.15% | 64.18% | 57.62% | 41.13% | 21.34% |
| EPS Diluted | 261.10% | 161.92% | 142.42% | -18.26% | -63.84% |
| Normalized Diluted EPS | 42.37% | 63.36% | 56.91% | 40.95% | 21.39% |
| Average Basic Shares Outstanding | 0.90% | 1.88% | 2.08% | 1.92% | 1.75% |
| Average Diluted Shares Outstanding | 1.40% | 2.38% | 2.54% | 2.08% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |